Abstract:Objective Expression of the human sodium/iodide symporter(hNIS)in the thyroid gland provides for effective imaging and treatment of thyroid cancer using radiolabeled iodide.Transfer of hNIS gene into other tumors would expand the utility of this treatment to tumors of nonthyroid origin.The human telomerase reverse transcriptase(hTERT)is overexpressed in tumor cells.but is not expressed in normal cells.The aim of this study was to construct a recombinant adenovirus containing the hNIS under the control of hTERT core promoter to express specially on tumor cells.and to investigate the feasibility of radioiodine therapy mediated by hNIS gene controlled with hTERT promoter.Methods The recombinant adenovirus Ad-hTERT-hNIS was constructed by AdEasy system.In addition.a positive control of adenovirus Adcytomegalovirus(CMV)-hNIS containing the CMV promoter followed with hNIS gene and a negative control of adenovirus Ad-CMV not containing hNIS gene were created by AdEasy system.The cell-specific transcriptional activity of hTERT was examined by reverse transcriptase-polymerase chain reaction(RT-PCR)in transiently transfected A549 cell lines.Iodide uptake assays were used to confirm hNIS expression and funetion.Toxic effects of131 I on tumor cells were studied by in vitro clonogenic assay.Results Recombinant Ad-hTERT-hNIS was correctly constructed and confirmed by restriction enzyme analysis and PCR.RT-PCRshowed that hNIS cDNA could be amplified by the transfeeted cells.A 23-fold and 31-fold increase in iodide uptake was observed in Ad-hTERT-hNIS and Ad-CMV-hNIS infected A549 cells.respectively.No significant iodide uptake increase was detected in cells infected with the negative control virus.The iodide uptake in transfected cells was inhibited by sodium perchlorate.In vitro elonogenic assay revealed that approximately 70%[(31.2 ±1.45)%A549 cells alive ] of Ad-hTERT-hNIS and 80%[(23.6 ±4.08)%A549 cells alive]of Ad-CMV-hNIS transfected A549 cells were killed by exposure to131 I.respectively.while only about 10% of NIS-negative control cells were killed [(89.0 ±2.99)%A549 cells alive for Ad-CMV group and(91.2 ± 4.63)%A549 cells alive for no-infected group ].Conclusion Radioiodine therapy following tumor cells transfected with recombinant adenovirus Ad-hTERT-hNIS may likely be a successful entity benefited by this novel gene targeting therapy strategy.

Therapeutic Effects of Adenovirus-Mediated CD and NIS Expression Combined with Na131I/5-FC on Human Thyroid Cancer.

Preparation of a Recombinant Adeno-Associated Virus Vector Encoding the Human NIS Gene and Its Expression in Thyroid Cancer Cell Lines

Efficient Multicistronic Co-Expression of Hnis and Htpo in Prostate Cancer Cells for Nonthyroidal Tumor Radioiodine Therapy.

Adenovirus-mediated Inhibitor Kappab Gene Transfer Improves the Chemosensitivity to Anticancer Drugs in Human Lung Cancer in Vitro and in Vivo.

Adenovirus-mediated Tissue-Specific Cytosine Deaminase Gene Therapy for Human Hepatocellular Carcinoma with Different AFP Expression Levels.

Radioiodide uptake and therapy of lung cancer cells mediated by human sodium iodide symporter gene

Combined Use of Chemotherapeutics and Oncolytic Adenovirus in Treatment of AFP-expressing Hepatocellular Carcinoma

In Vivo Molecular Imaging And Radionuclide (I-131) Therapy Of Human Nasopharyngeal Carcinoma Cells Transfected With A Lentivirus Expressing Sodium Iodide Symporter

Experimental Study of Baculovirus-Mediated Transfer of the Thyroid Sodium/iodide Symporter Gene into Thyroid Cancer for Targeted Radiotherapy

Combining Transfer of Ttf-1 and Pax-8 Gene: A Potential Strategy to Promote Radioiodine Therapy of Thyroid Carcinoma

In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporter

Enhanced EJ Cell Killing of (125)I Radiation by Combining with Cytosine Deaminase Gene Therapy Regulated by Synthetic Radio-Responsive Promoter.

Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.

[Adenovirus-Mediated Interleukin-24 Enhanced the Antitumor Effect of Radiotherapy on Nasopharyngeal Carcinoma in Vitro and in Vivo].

Combined Therapy with Ctl Cells and Oncolytic Adenovirus Expressing Il-15-Induced Enhanced Antitumor Activity

Antitumor effect of combined therapy with adenovirus-mediated CD suicide gene and interleukin 2 gene transfer and its immunological mechanism]

Adenovirus-mediated combined suicide gene and interleukin-2 gene therapy for the treatment of established tumor and induction of antitumor immunity

Inhibiting Β-Catenin Expression Promotes Efficiency of Radioiodine Treatment in Aggressive Follicular Thyroid Cancer Cells Probably Through Mediating NIS Localization.

Antitumor and Radiosensitization Effect of 12 C 6+ Heavy-Ion Irradiation Mediated by Radiation-Inducible Gene Therapy

Baculovirus vector-mediated transfer of sodium iodide symporter and plasminogen kringle 5 genes for tumor radioiodide therapy.

Adenovirus-Mediated Combined Anti-Angiogenic and Pro-Apoptotic Gene Therapy Enhances Antitumor Efficacy in Hepatocellular Carcinoma